Research Group
Carloni Group
Microbial Systems and Human Interfaces (MSHI) Lab
Our research aims to decode and reprogram microbial communication systems — ranging from small molecules and quorum sensing signals to bacterial extracellular vesicles — that drive disease trajectories in inflammatory bowel disease and across the gut–brain and gut–tumor axes.
The challenge
Current microbiome research is largely descriptive and fails to capture the functional logic of microbial systems. Microorganisms act as coordinated communities that communicate through structured signaling networks – including quorum sensing molecules and bacterial extracellular vesicles (BEVs) – yet these signals remain largely undefined in human disease.
A key challenge is understanding how microbial communication interacts with host barrier interfaces and propagates across tissues to shape systemic outcomes, particularly in inflammatory bowel disease, early-onset colorectal cancer, and gut–brain disorders.
Our research addresses this gap by reframing the microbiota as microbiology at a different resolution. We focus on identifying, mapping, and ultimately reprogramming microbial signals to uncover causal mechanisms and develop actionable biomarkers and therapeutic strategies.
Main research areas
Human-centered multi-omics and microbial communication systems
We use deeply phenotyped clinical cohorts to identify microbial communication signals — including quorum sensing molecules, metabolites, and bacterial extracellular vesicles (BEVs) — associated with disease trajectories in inflammatory bowel disease (IBD), early-onset colorectal cancer (EO-CRC), and extraintestinal manifestations such as anxiety and depression.
We integrate multi-omics across compartments to define functional microbial networks beyond compositional descriptions.
Microbial signal tropism
We map signal tropism across tissues to define how microbial communication propagates systemically and influences brain and tumor responses.
Microbial rewiring of communication networks
We develop strategies to reprogram microbial communication by modulating quorum sensing, metabolism, and vesicle production.
Our goal is to shift microbial communities from disease-associated states to functional configurations with therapeutic potential.
BEVs as liquid biopsy of microbial functional states and biofilm dynamics
We investigate bacterial extracellular vesicles as accessible readouts of microbial communication and biofilm-associated states.
By capturing vesicle-derived signals in biological fluids, we develop liquid biopsy approaches to monitor microbial activity, detect functional dysbiosis, and track disease progression or response to therapy.
Selected publications
Maternal gut microbiota influences immune activation at the maternal-fetal interface affecting pregnancy outcome
Distinct chromosomal mutation associated with cefiderocol resistance in Acinetobacter baumannii: a combined bioinformatics and mass spectrometry approach to unveil and validate the in vivo-acquired chemoresistance
Microbial composition associated with biliary stents in patients undergoing pancreatic resection for cancer
The gut-brain vascular axis in neuroinflammation
Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers
Identification of a choroid plexus vascular barrier closing during intestinal inflammation.
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver.
Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth.
Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells
The small RNA ReaL: a novel regulatory element embedded in the Pseudomonas aeruginosa quorum sensing networks
Group members